ARCHIVES

John Niederhuber Named Acting NCI Director.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Study Finds Trial Results Reliable At Three Years

July 29, 2005

In Brief: Broder Keynote Speaker At ACCC Meeting; Tefft To Head Radiation Therapy At Cleveland Clinic

February 24, 1989

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

November 2, 2002

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993